{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T12:32:36Z","timestamp":1723552356623},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,6,15]],"date-time":"2014-06-15T00:00:00Z","timestamp":1402790400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Addict Rep"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s40429-014-0025-8","type":"journal-article","created":{"date-parts":[[2014,6,19]],"date-time":"2014-06-19T03:22:37Z","timestamp":1403148157000},"page":"237-242","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Psychostimulant Abuse and HIV Infection: Cocaine, Methamphetamine, and \u2018Bath Salts\u2019 Cathinone Analogs"],"prefix":"10.1007","volume":"1","author":[{"given":"Brenda M.","family":"Gannon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily E.","family":"Reichard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William E.","family":"Fantegrossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,15]]},"reference":[{"key":"25_CR1","unstructured":"Centers for Disease Control and Prevention, National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention. HIV in the United States: at a glance. 2012. Available from: http:\/\/www.cdc.gov\/hiv\/resources\/factsheets\/PDF\/HIV_at_a_glance.pdf ."},{"key":"25_CR2","unstructured":"World Health Organization. Global Health Observatory (GHO). HIV\/AIDS. 2012. Available from: http:\/\/www.who.int\/gho\/hiv\/en\/ ."},{"issue":"1","key":"25_CR3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11904-010-0069-x","volume":"8","author":"PR Gorry","year":"2011","unstructured":"Gorry PR, Ancuta P. Coreceptors and HIV-1 pathogenesis. Curr HIV\/AIDS Rep. 2011;8(1):45\u201353.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"5","key":"25_CR4","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.neubiorev.2008.01.004","volume":"32","author":"MJ Ferris","year":"2008","unstructured":"Ferris MJ, Mactutus CF, Booze RM. Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS. Neurosci Biobehav Rev. 2008;32(5):883\u2013909. This review examines the vulnerability of the DA system to neurotoxicity as a result of the concerted effects of psychostimulant drug use and HIV in NeuroAIDS.","journal-title":"Neurosci Biobehav Rev"},{"issue":"5","key":"25_CR5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s13365-011-0043-4","volume":"17","author":"P Silverstein","year":"2011","unstructured":"Silverstein P et al. Methamphetamine toxicity and its implications during HIV-1 infection. J Neurovirol. 2011;17(5):401\u201315.","journal-title":"J Neurovirol"},{"issue":"5","key":"25_CR6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2174\/157016212802138823","volume":"10","author":"S Buch","year":"2012","unstructured":"Buch S et al. Cocaine and HIV-1 interplay in CNS: cellular and molecular mechanisms. Curr HIV Res. 2012;10(5):425\u20138. This reviews the CNS effects elicited by cocaine and examines the cellular and molecular mechanisms of interaction between cocaine and HIV-1 in the CNS.","journal-title":"Curr HIV Res"},{"issue":"1","key":"25_CR7","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1600-065X.2012.01094.x","volume":"246","author":"JK Chan","year":"2012","unstructured":"Chan JK, Greene WC. Dynamic roles for NF-\u03baB in HTLV-I and HIV-1 retroviral pathogenesis. Immunol Rev. 2012;246(1):286\u2013310.","journal-title":"Immunol Rev"},{"issue":"8","key":"25_CR8","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1093\/nar\/gkr1224","volume":"40","author":"G Fiume","year":"2012","unstructured":"Fiume G et al. Human immunodeficiency virus-1 Tat activates NF-\u03baB via physical interaction with I\u03baB-\u03b1 and p65. Nucleic Acids Res. 2012;40(8):3548\u201362.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"25_CR9","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.neuroscience.2009.01.024","volume":"159","author":"M Ferris","year":"2009","unstructured":"Ferris M et al. The human immunodeficiency virus-1-associated protein, Tat1-86, impairs dopamine transporters and interacts with cocaine to reduce nerve terminal function: a no-net-flux microdialysis study. Neuroscience. 2009;159(4):1292\u20139.","journal-title":"Neuroscience"},{"issue":"5","key":"25_CR10","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2174\/157016212802138742","volume":"10","author":"MP Nair","year":"2012","unstructured":"Nair MP, Samikkannu T. Differential regulation of neurotoxin in HIV clades: role of cocaine and methamphetamine. Curr HIV Res. 2012;10(5):429\u201334. This review examines how neurotoxins are differentially regulated in cocaine- and METH-using HIV infected populations.","journal-title":"Curr HIV Res"},{"issue":"13","key":"25_CR11","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1503\/cmaj.071675","volume":"178","author":"SJ Kish","year":"2008","unstructured":"Kish SJ. Pharmacologic mechanisms of crystal meth. CMAJ. 2008;178(13):1679\u201382.","journal-title":"CMAJ"},{"issue":"7","key":"25_CR12","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3109\/15563650.2010.516263","volume":"48","author":"D Seger","year":"2010","unstructured":"Seger D. Cocaine, methamphetamine, and MDMA abuse: the role and clinical importance of neuroadaptation. Clin Toxicol (Phila). 2010;48(7):695\u2013708.","journal-title":"Clin Toxicol (Phila)"},{"issue":"1\u20132","key":"25_CR13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0014-2999(02)01985-4","volume":"449","author":"E Riddle","year":"2002","unstructured":"Riddle E et al. Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine. Eur J Pharmacol. 2002;449(1\u20132):71\u20134.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"25_CR14","doi-asserted-by":"crossref","first-page":"E413","DOI":"10.1007\/BF02854914","volume":"8","author":"EL Riddle","year":"2006","unstructured":"Riddle EL, Fleckenstein AE, Hanson GR. Mechanisms of methamphetamine-induced dopaminergic neurotoxicity. AAPS J. 2006;8(2):E413\u20138.","journal-title":"AAPS J"},{"issue":"2","key":"25_CR15","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neuroscience.2007.09.044","volume":"150","author":"P Simoes","year":"2007","unstructured":"Simoes P et al. Methamphetamine induces alterations on hippocampal NMDA and AMPA receptor subunit levels and impairs spatial working memory. Neuroscience. 2007;150(2):433\u201341.","journal-title":"Neuroscience"},{"issue":"1","key":"25_CR16","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1146\/annurev.pharmtox.47.120505.105140","volume":"47","author":"A Fleckenstein","year":"2007","unstructured":"Fleckenstein A et al. New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol. 2007;47(1):681\u201398.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"25_CR17","doi-asserted-by":"crossref","unstructured":"Gon\u00e7alves J, Baptista S, Silva AP. Pyschostimulants and brain dysfunction: a review of the relevant neurotoxic effects. Neuropharmacology. 2014.","DOI":"10.1016\/j.neuropharm.2014.01.006"},{"issue":"1","key":"25_CR18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.lfs.2013.07.014","volume":"97","author":"LE Halpin","year":"2014","unstructured":"Halpin LE, Collins SA, Yamamoto BK. Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine. Life Sci. 2014;97(1):37\u201344.","journal-title":"Life Sci"},{"key":"25_CR19","unstructured":"National Institute on Drug Abuse. Drug abuse and AIDS. NIDA InfoFacts. Nov 2004. Available from: www.drugabuse.gov ."},{"issue":"1\u20133","key":"25_CR20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejphar.2003.08.054","volume":"479","author":"RB Rothman","year":"2003","unstructured":"Rothman RB, Baumann MH. Monoamine transporters and psychostimulant drugs. Eur J Pharmacol. 2003;479(1\u20133):23\u201340.","journal-title":"Eur J Pharmacol"},{"key":"25_CR21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-59259-470-2_3","volume-title":"Neurotransmitter transporters: structure, function and regulation","author":"G Rudnick","year":"1997","unstructured":"Rudnick G. Mechanisms of biogenic amine transporters. In: Reith MEA, editor. Neurotransmitter transporters: structure, function and regulation. Totowa: Humana Press; 1997. p. 73\u2013100."},{"key":"25_CR22","first-page":"249","volume":"1144","author":"G Rudnick","year":"1993","unstructured":"Rudnick G, Clark J. From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters. Biochem Biophys Acta. 1993;1144:249\u201363.","journal-title":"Biochem Biophys Acta"},{"issue":"1","key":"25_CR23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12035-011-8195-z","volume":"44","author":"V Purohit","year":"2011","unstructured":"Purohit V, Rapaka R, Shurtleff D. Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders\/HIV-associated dementia. Mol Neurobiol. 2011;44(1):102\u201310. This review examines the role drug use has on DA in HAND\/HAD.","journal-title":"Mol Neurobiol"},{"key":"25_CR24","doi-asserted-by":"crossref","unstructured":"Meyer V, et al. Crack cocaine use impairs anterior cingulate and prefrontal cortex function in women with HIV infection. J Neurovirol. 2014.","DOI":"10.1007\/s13365-014-0250-x"},{"issue":"10","key":"25_CR25","doi-asserted-by":"crossref","first-page":"e13427","DOI":"10.1371\/journal.pone.0013427","volume":"5","author":"Y Yang","year":"2010","unstructured":"Yang Y et al. Cocaine potentiates astrocyte toxicity mediated by human immunodeficiency virus (HIV-1) protein gp120. PLoS One. 2010;5(10):e13427.","journal-title":"PLoS One"},{"issue":"3","key":"25_CR26","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s11481-014-9524-6","volume":"9","author":"T Napier","year":"2014","unstructured":"Napier T et al. Repeated cocaine treatment enhances HIV-1 Tat-induced cortical excitability via over-activation of L-type calcium channels. J NeuroImmune Pharmacol. 2014;9(3):354\u201368.","journal-title":"J NeuroImmune Pharmacol"},{"issue":"4","key":"25_CR27","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.ajpath.2013.12.004","volume":"184","author":"J Pandhare","year":"2014","unstructured":"Pandhare J et al. Cocaine enhances HIV-1-induced CD4(+) T-cell apoptosis: implications in disease progression in cocaine-abusing HIV-1 patients. Am J Pathol. 2014;184(4):927\u201336.","journal-title":"Am J Pathol"},{"key":"25_CR28","unstructured":"Centers for Disease Control and Prevention. Drug-associated HIV transmission continues in the United States. 2002. Available from: http:\/\/www.cdc.gov\/hiv\/resources\/Factsheets\/PDF\/idu.pdf ."},{"issue":"11","key":"25_CR29","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1089\/aid.2008.0282","volume":"25","author":"S Toussi","year":"2009","unstructured":"Toussi S et al. Short communication: methamphetamine treatment increases in vitro and in vivo HIV replication. AIDS Res Hum Retrovir. 2009;25(11):1117\u201321.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"6","key":"25_CR30","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2353\/ajpath.2008.070971","volume":"172","author":"H Liang","year":"2008","unstructured":"Liang H et al. Methamphetamine enhances HIV infection of macrophages. Am J Pathol. 2008;172(6):1617\u201324.","journal-title":"Am J Pathol"},{"issue":"2","key":"25_CR31","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.neuroscience.2007.11.007","volume":"151","author":"W Fantegrossi","year":"2008","unstructured":"Fantegrossi W et al. A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse. Neuroscience. 2008;151(2):533\u201343.","journal-title":"Neuroscience"},{"key":"25_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.104.070961","volume":"311","author":"D Thomas","year":"2004","unstructured":"Thomas D et al. Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation. J Pharmacol Exp Ther. 2004;311:1\u20137.","journal-title":"J Pharmacol Exp Ther"},{"key":"25_CR33","doi-asserted-by":"crossref","first-page":"5756","DOI":"10.1523\/JNEUROSCI.1179-08.2008","volume":"28","author":"Y Sekine","year":"2008","unstructured":"Sekine Y et al. Methamphetamine causes microglial activation in the brains of human abusers. J Neurosci. 2008;28:5756\u201361.","journal-title":"J Neurosci"},{"issue":"5","key":"25_CR34","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s13365-012-0103-4","volume":"18","author":"E Wires","year":"2012","unstructured":"Wires E et al. Methamphetamine activates nuclear factor kappa-light-chain-enhancer of activated B cells (NF-\u03baB) and induces human immunodeficiency virus (HIV) transcription in human microglial cells. J Neurovirol. 2012;18(5):400\u201310.","journal-title":"J Neurovirol"},{"key":"25_CR35","doi-asserted-by":"crossref","unstructured":"Kesby J, et al. Expression of HIV gp120 protein increases sensitivity to the rewarding properties of methamphetamine in mice. Addict Biol. 2012.","DOI":"10.1111\/adb.12023"},{"issue":"1","key":"25_CR36","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ajpath.2013.09.011","volume":"184","author":"C Mantri","year":"2014","unstructured":"Mantri C et al. Methamphetamine inhibits HIV-1 replication in CD4+ T cells by modulating anti-HIV-1 miRNA expression. Am J Pathol. 2014;184(1):92\u2013100.","journal-title":"Am J Pathol"},{"issue":"5","key":"25_CR37","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/npp.2011.304","volume":"37","author":"M Baumann","year":"2012","unstructured":"Baumann M et al. The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology. 2012;37(5):1192\u2013203. This study defines the mechanism of action for two common \u2018bath salt\u2019 constituents as amphetamine-like substrates\/releasers at monoamine transporters.","journal-title":"Neuropsychopharmacology"},{"issue":"1\u20133","key":"25_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2012.11.020","volume":"698","author":"MH Baumann","year":"2013","unstructured":"Baumann MH, Partilla JS, Lehne KR. Psychoactive \u201cbath salts\u201d: not so soothing. Eur J Pharmacol. 2013;698(1\u20133):1\u20135. This study defines the mechanism of action of common \u201cbath salt\u201d constituents at monoamine transporters compared with cocaine.","journal-title":"Eur J Pharmacol"},{"issue":"1\u20133","key":"25_CR39","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejphar.2012.12.006","volume":"700","author":"L Iversen","year":"2013","unstructured":"Iversen L et al. Neurochemical profiles of somenovel psychoactive substances. Eur J Pharmacol. 2013;700(1\u20133):147\u201351.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"25_CR40","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1476-5381.2012.02145.x","volume":"168","author":"L Simmler","year":"2013","unstructured":"Simmler L et al. Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol. 2013;168(2):458\u201370. This study defines the affinity of common \u2018bath salt\u2019 constituents for monoamine transporters and their capacity to act as DA and 5-HT releasers compared with well-known drugs of abuse, such as cocaine and methamphetamine.","journal-title":"Br J Pharmacol"},{"key":"25_CR41","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neuropharm.2013.04.003","volume":"71","author":"S Aarde","year":"2013","unstructured":"Aarde S et al. The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats. Neuropharmacology. 2013;71:130\u201340.","journal-title":"Neuropharmacology"},{"issue":"2","key":"25_CR42","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1369-1600.2012.00474.x","volume":"19","author":"L Watterson","year":"2014","unstructured":"Watterson L et al. Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV). Addict Biol. 2014;19(2):165\u201374.","journal-title":"Addict Biol"},{"key":"25_CR43","doi-asserted-by":"crossref","unstructured":"Watterson L, et al. The reinforcing and rewarding effects of methylone, a synthetic cathinone commonly found in \u201cbath salts\u201d. J Addict Res Ther. 2012; Suppl 9. doi: 10.4172\/2155-6105.S9-002 .","DOI":"10.4172\/2155-6105.S9-002"}],"container-title":["Current Addiction Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40429-014-0025-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40429-014-0025-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40429-014-0025-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T14:02:13Z","timestamp":1565532133000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40429-014-0025-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,15]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["25"],"URL":"https:\/\/doi.org\/10.1007\/s40429-014-0025-8","relation":{},"ISSN":["2196-2952"],"issn-type":[{"value":"2196-2952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,15]]}}}